ENVB logo

Enveric Biosciences (ENVB) EBITDA

Annual EBITDA

-$17.89 M
+$1.63 M+8.34%

December 31, 2023

Summary

Performance

1-Year Change

+8.34%

3-Year Change

-184.01%

5-Year Change

-158.67%

15-Year Change

-133.1%

ENVB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.63%
ENVB annual EBITDA is higher than 54.63% of companies in Healthcare sector

High & Low

All-time High

$559.10 K
ENVB annual EBITDA is currently -3299.53% below its historical high of $559.10 thousand

3-Year Low

-$55.74 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ENVB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
ENVB next annual earnings announcement is scheduled for Mar 26, 2025

OtherENVBprofitabilitymetrics:

Annual Revenue

-
ENVB annual revenue value is unknown

Annual Net Income

-$17.31 M
ENVB annual net profit is -$17.31 million

Annual EBIT

-$18.30 M
ENVB annual earnings before interest & taxes is -$18.30 million

Annual EPS

-$121.35
ENVB annual earnings per share is -$121.35

Quarterly EBITDA

-$2.00 M
-$185.20 K-10.21%

September 30, 2024

Summary

Performance

3-Month Change

-10.21%

1-Year Change

-10.21%

3-Year Change

+57.5%

5-Year Change

-99.24%

ENVB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.89%
ENVB quarterly EBITDA is higher than 62.89% of companies in Healthcare sector

High & Low

All-time High

$6.55 M
ENVB quarterly EBITDA is currently -130.50% below its historical high of $6.55 million

3-Year Low

-$49.36 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENVB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
ENVB next earnings announcement is scheduled for Mar 26, 2025

OtherENVBprofitabilitymetrics:

Quarterly Revenue

-
ENVB quarterly revenue value is unknown

Quarterly Net Income

-$2.08 M
ENVB quarterly net profit is -$2.08 million

Quarterly EBIT

-$2.08 M
ENVB quarterly earnings before interest & taxes is -$2.08 million

Quarterly EPS

-$3.60
ENVB quarterly earnings per share is -$3.60

TTM EBITDA

-$10.35 M
+$1.35 M+11.57%

September 30, 2024

Summary

Performance

3-Month Change

+11.57%

1-Year Change

+11.57%

3-Year Change

+40.25%

5-Year Change

-457.67%

ENVB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.79%
ENVB TTM EBITDA is higher than 60.79% of companies in Healthcare sector

High & Low

All-time High

$3.40 M
ENVB TTM EBITDA is currently -404.54% below its historical high of $3.40 million

3-Year Low

-$61.98 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ENVB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
ENVB next earnings announcement is scheduled for Mar 26, 2025

OtherENVBprofitabilitymetrics:

TTM Revenue

-
ENVB TTM revenue value is unknown

TTM Net Income

-$9.86 M
ENVB TTM net profit is -$9.86 million

TTM EBIT

-$10.69 M
ENVB TTM earnings before interest & taxes is -$10.69 million

TTM EPS

-$38.55
ENVB TTM earnings per share is -$38.55

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$17.89 M
ENVB annual EBITDA is -$17.89 million

Annual Net Income

-$17.31 M
ENVB annual net profit is -$17.31 million

Annual Interest Expense

-
ENVB annual interest expense value is unknown

Annual Income Tax

$28.90 K
ENVB annual income tax is $28.90 thousand

Annual D&A

$408.00 K
ENVB annual depreciation & amortization is $408.00 thousand

ENVB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.3%-10.2%+11.6%
3 y3 years-184.0%+57.5%+40.3%
5 y5 years-158.7%-99.2%-457.7%

ENVB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+67.9%-10.2%+96.0%at high+83.3%
5 y5-year-691.9%+67.9%-308.8%+96.0%-670.8%+83.3%
alltimeall time-3299.5%+67.9%-130.5%+96.0%-404.5%+83.3%

Enveric Biosciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.00 M(+10.2%)
-$10.35 M(-11.6%)
Jun 2024
-
-$1.81 M(-24.2%)
-$11.71 M(-24.6%)
Mar 2024
-
-$2.39 M(-42.3%)
-$15.53 M(-13.2%)
Dec 2023
-$17.89 M(-8.3%)
-$4.15 M(+23.7%)
-$17.89 M(-3.0%)
Sep 2023
-
-$3.35 M(-40.6%)
-$18.44 M(-10.6%)
Jun 2023
-
-$5.64 M(+18.8%)
-$20.63 M(+16.8%)
Mar 2023
-
-$4.75 M(+1.0%)
-$17.66 M(+1.9%)
Dec 2022
-$19.52 M(-65.0%)
-$4.70 M(-15.1%)
-$17.32 M(-72.0%)
Sep 2022
-
-$5.54 M(+107.3%)
-$61.98 M(+5.1%)
Jun 2022
-
-$2.67 M(-39.5%)
-$58.98 M(+3.4%)
Mar 2022
-
-$4.42 M(-91.1%)
-$57.04 M(+2.3%)
Dec 2021
-$55.74 M(+785.0%)
-$49.36 M(+1844.5%)
-$55.74 M(+426.5%)
Sep 2021
-
-$2.54 M(+248.0%)
-$10.59 M(+24.0%)
Jun 2021
-
-$729.40 K(-76.6%)
-$8.54 M(-0.4%)
Mar 2021
-
-$3.11 M(-25.9%)
-$8.58 M(+31.8%)
Dec 2020
-$6.30 M(+178.8%)
-$4.20 M(+758.4%)
-$6.50 M(+384.3%)
Sep 2020
-
-$489.80 K(-36.2%)
-$1.34 M(-27.6%)
Jun 2020
-
-$767.50 K(-26.4%)
-$1.86 M(+15.3%)
Mar 2020
-
-$1.04 M(-209.0%)
-$1.61 M(-8.2%)
Dec 2019
-$2.26 M(-67.3%)
$957.30 K(-195.4%)
-$1.75 M(-88.6%)
Sep 2019
-
-$1.00 M(+92.6%)
-$15.37 M(+96.7%)
Jun 2019
-
-$520.70 K(-56.2%)
-$7.82 M(+3.3%)
Mar 2019
-
-$1.19 M(-90.6%)
-$7.56 M(+9.4%)
Dec 2018
-$6.92 M(-9.9%)
-$12.66 M(-293.2%)
-$6.92 M(-303.5%)
Sep 2018
-
$6.55 M(-2540.9%)
$3.40 M(-154.3%)
Jun 2018
-
-$268.40 K(-50.3%)
-$6.26 M(-24.3%)
Mar 2018
-
-$539.90 K(-77.0%)
-$8.27 M(+7.7%)
Dec 2017
-$7.67 M(+73.9%)
-$2.34 M(-24.6%)
-$7.67 M(+8.7%)
Sep 2017
-
-$3.11 M(+36.8%)
-$7.06 M(+43.3%)
Jun 2017
-
-$2.27 M(-4280.1%)
-$4.93 M(+41.2%)
Mar 2017
-
$54.40 K(-103.1%)
-$3.49 M(-20.9%)
Dec 2016
-$4.41 M(+720.5%)
-$1.73 M(+76.7%)
-$4.41 M(+64.4%)
Sep 2016
-
-$977.80 K(+16.8%)
-$2.68 M(+33.4%)
Jun 2016
-
-$837.10 K(-3.8%)
-$2.01 M(+103.7%)
Mar 2016
-
-$870.00 K(+184.0%)
-$988.30 K(+654.4%)
Dec 2015
-$537.80 K(+1539.6%)
-
-
Sep 2015
-
-$306.30 K(-262.9%)
-$131.00 K(-176.1%)
Jun 2015
-
$188.00 K(-8273.9%)
$172.20 K(-726.2%)
Mar 2015
-
-$2300.00(-77.9%)
-$27.50 K(-16.2%)
Dec 2014
-$32.80 K(+20.6%)
-$10.40 K(+235.5%)
-$32.80 K(-10.1%)
Sep 2014
-
-$3100.00(-73.5%)
-$36.50 K(-3.9%)
Jun 2014
-
-$11.70 K(+53.9%)
-$38.00 K(+25.8%)
Mar 2014
-
-$7600.00(-46.1%)
-$30.20 K(+10.6%)
Dec 2013
-$27.20 K(+19.8%)
-$14.10 K(+206.5%)
-$27.30 K(+17.7%)
Sep 2013
-
-$4600.00(+17.9%)
-$23.20 K(0.0%)
Jun 2013
-
-$3900.00(-17.0%)
-$23.20 K(-0.9%)
Mar 2013
-
-$4700.00(-53.0%)
-$23.40 K(+3.1%)
Dec 2012
-$22.70 K(-27.7%)
-$10.00 K(+117.4%)
-$22.70 K(-11.7%)
Sep 2012
-
-$4600.00(+12.2%)
-$25.70 K(+3.6%)
Jun 2012
-
-$4100.00(+2.5%)
-$24.80 K(+2.1%)
Mar 2012
-
-$4000.00(-69.2%)
-$24.30 K(-22.6%)
Dec 2011
-$31.40 K(-12.5%)
-$13.00 K(+251.4%)
-$31.40 K(+5.4%)
Sep 2011
-
-$3700.00(+2.8%)
-$29.80 K(-6.0%)
Jun 2011
-
-$3600.00(-67.6%)
-$31.70 K(-2.8%)
Mar 2011
-
-$11.10 K(-2.6%)
-$32.60 K(-9.2%)
Dec 2010
-$35.90 K(-35.4%)
-$11.40 K(+103.6%)
-$35.90 K(-20.8%)
Sep 2010
-
-$5600.00(+24.4%)
-$45.30 K(+2.5%)
Jun 2010
-
-$4500.00(-68.8%)
-$44.20 K(-17.1%)
Mar 2010
-
-$14.40 K(-30.8%)
-$53.30 K(-4.1%)
Dec 2009
-$55.60 K
-$20.80 K(+362.2%)
-$55.60 K(-20.3%)
Sep 2009
-
-$4500.00(-66.9%)
-$69.80 K(-4.4%)
DateAnnualQuarterlyTTM
Jun 2009
-
-$13.60 K(-18.6%)
-$73.00 K(-23.9%)
Mar 2009
-
-$16.70 K(-52.3%)
-$95.90 K(-36.0%)
Dec 2008
-$151.40 K(-28.0%)
-$35.00 K(+354.5%)
-$149.90 K(-76.7%)
Sep 2008
-
-$7700.00(-78.9%)
-$643.50 K(-7.4%)
Jun 2008
-
-$36.50 K(-48.4%)
-$695.00 K(+37.4%)
Mar 2008
-
-$70.70 K(-86.6%)
-$505.80 K(+155.2%)
Dec 2007
-$210.40 K(-33.5%)
-$528.60 K(+792.9%)
-$198.20 K(-170.6%)
Sep 2007
-
-$59.20 K(-138.8%)
$280.60 K(-2.6%)
Jun 2007
-
$152.70 K(-35.5%)
$288.20 K(+238.7%)
Mar 2007
-
$236.90 K(-575.7%)
$85.10 K(-126.9%)
Dec 2006
-$316.30 K(+637.3%)
-$49.80 K(-3.5%)
-$316.40 K(-29.2%)
Sep 2006
-
-$51.60 K(+2.4%)
-$446.60 K(+27.0%)
Jun 2006
-
-$50.40 K(-69.4%)
-$351.60 K(+50.8%)
Mar 2006
-
-$164.60 K(-8.6%)
-$233.10 K(+443.4%)
Dec 2005
-$42.90 K(-53.8%)
-$180.00 K(-514.7%)
-$42.90 K(-113.7%)
Sep 2005
-
$43.40 K(-36.3%)
$312.50 K(+51.8%)
Jun 2005
-
$68.10 K(+166.0%)
$205.90 K(+446.2%)
Mar 2005
-
$25.60 K(-85.4%)
$37.70 K(-140.6%)
Dec 2004
-$92.90 K(-76.8%)
$175.40 K(-377.5%)
-$92.90 K(-73.6%)
Sep 2004
-
-$63.20 K(-36.9%)
-$351.90 K(-5.5%)
Jun 2004
-
-$100.10 K(-4.7%)
-$372.50 K(-19.1%)
Mar 2004
-
-$105.00 K(+25.6%)
-$460.60 K(+14.9%)
Dec 2003
-$400.90 K(-434.9%)
-$83.60 K(-0.2%)
-$400.90 K(+32.3%)
Sep 2003
-
-$83.80 K(-55.5%)
-$303.10 K(+60.7%)
Jun 2003
-
-$188.20 K(+315.5%)
-$188.60 K(-969.1%)
Mar 2003
-
-$45.30 K(-419.0%)
$21.70 K(-81.8%)
Dec 2002
$119.70 K(-167.8%)
$14.20 K(-53.7%)
$119.50 K(-18.2%)
Sep 2002
-
$30.70 K(+38.9%)
$146.00 K(-448.4%)
Jun 2002
-
$22.10 K(-57.9%)
-$41.90 K(-70.6%)
Mar 2002
-
$52.50 K(+29.0%)
-$142.70 K(-19.2%)
Dec 2001
-$176.60 K(-139.8%)
$40.70 K(-125.9%)
-$176.70 K(-27.4%)
Sep 2001
-
-$157.20 K(+99.7%)
-$243.50 K(-749.3%)
Jun 2001
-
-$78.70 K(-525.4%)
$37.50 K(-85.2%)
Mar 2001
-
$18.50 K(-170.9%)
$253.40 K(-42.9%)
Dec 2000
$444.10 K(-20.6%)
-$26.10 K(-121.1%)
$444.10 K(-5.6%)
Sep 2000
-
$123.80 K(-9.8%)
$470.20 K(+35.7%)
Jun 2000
-
$137.20 K(-34.4%)
$346.40 K(+65.6%)
Mar 2000
-
$209.20 K(-85.9%)
$209.20 K(-111.5%)
Dec 1999
$559.10 K(-130.8%)
-
-
Dec 1998
-$1.82 M(-57.5%)
$1.48 M(-223.5%)
-$1.82 M(-59.4%)
Sep 1998
-
-$1.20 M(+9.1%)
-$4.48 M(+9.8%)
Jun 1998
-
-$1.10 M(+10.0%)
-$4.08 M(0.0%)
Mar 1998
-
-$1.00 M(-15.2%)
-$4.08 M(0.0%)
Dec 1997
-$4.28 M(-82.9%)
-$1.18 M(+47.4%)
-$4.08 M(-83.3%)
Sep 1997
-
-$800.00 K(-27.3%)
-$24.37 M(-0.8%)
Jun 1997
-
-$1.10 M(+10.0%)
-$24.57 M(-2.0%)
Mar 1997
-
-$1.00 M(-95.3%)
-$25.07 M(+0.8%)
Dec 1996
-$25.07 M(+659.8%)
-$21.47 M(+2047.4%)
-$24.87 M(+227.3%)
Sep 1996
-
-$1.00 M(-37.5%)
-$7.60 M(+20.6%)
Jun 1996
-
-$1.60 M(+100.0%)
-$6.30 M(+43.2%)
Mar 1996
-
-$800.00 K(-81.0%)
-$4.40 M(+33.3%)
Dec 1995
-$3.30 M(+200.0%)
-$4.20 M(-1500.0%)
-$3.30 M(-430.0%)
Sep 1995
-
$300.00 K(0.0%)
$1.00 M(-176.9%)
Jun 1995
-
$300.00 K(0.0%)
-$1.30 M(-13.3%)
Mar 1995
-
$300.00 K(+200.0%)
-$1.50 M(-11.8%)
Dec 1994
-$1.10 M(-38.9%)
-
-
Nov 1994
-
$100.00 K(-105.0%)
-$1.70 M(0.0%)
Aug 1994
-
-$2.00 M(-2100.0%)
-$1.70 M(-666.7%)
Aug 1994
-$1.80 M
-
-
May 1994
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Feb 1994
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
Nov 1993
-
$100.00 K
$100.00 K

FAQ

  • What is Enveric Biosciences annual EBITDA?
  • What is the all time high annual EBITDA for Enveric Biosciences?
  • What is Enveric Biosciences annual EBITDA year-on-year change?
  • What is Enveric Biosciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Enveric Biosciences?
  • What is Enveric Biosciences quarterly EBITDA year-on-year change?
  • What is Enveric Biosciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Enveric Biosciences?
  • What is Enveric Biosciences TTM EBITDA year-on-year change?

What is Enveric Biosciences annual EBITDA?

The current annual EBITDA of ENVB is -$17.89 M

What is the all time high annual EBITDA for Enveric Biosciences?

Enveric Biosciences all-time high annual EBITDA is $559.10 K

What is Enveric Biosciences annual EBITDA year-on-year change?

Over the past year, ENVB annual EBITDA has changed by +$1.63 M (+8.34%)

What is Enveric Biosciences quarterly EBITDA?

The current quarterly EBITDA of ENVB is -$2.00 M

What is the all time high quarterly EBITDA for Enveric Biosciences?

Enveric Biosciences all-time high quarterly EBITDA is $6.55 M

What is Enveric Biosciences quarterly EBITDA year-on-year change?

Over the past year, ENVB quarterly EBITDA has changed by -$185.20 K (-10.21%)

What is Enveric Biosciences TTM EBITDA?

The current TTM EBITDA of ENVB is -$10.35 M

What is the all time high TTM EBITDA for Enveric Biosciences?

Enveric Biosciences all-time high TTM EBITDA is $3.40 M

What is Enveric Biosciences TTM EBITDA year-on-year change?

Over the past year, ENVB TTM EBITDA has changed by +$1.35 M (+11.57%)